News
Glycosyltransferases (GTs) are enzymes that transfer sugars from donor to an acceptor molecule. There are dozens of GT gene families, classified by sequence, sequence motifs and enzymatic function.
News
Glycosyltransferases (GTs) are enzymes that transfer sugars from donor to an acceptor molecule. There are dozens of GT gene families, classified by sequence, sequence motifs and enzymatic function.
Press release
University of Dundee research that aims to develop a new male contraceptive has been boosted by major new funding from the Bill & Melinda Gates Foundation.
Press release
The expansion of an exemplary industry-academia collaboration will see the University of Dundee intensify its efforts to develop new medicines that target and destroy key cancer-causing proteins, which have previously been regarded as undruggable
News
Joana Faria, a postdoctoral researcher in David Horn’s Lab (BCDD-WCAIR) has been awarded a Sir Henry Dale Fellowship funded by the Wellcome Trust and the Royal Society.
Press release
Almost half a million rapid diagnostic tests developed from research at the University of Dundee will be donated with the aim of helping eliminate the disease known as African sleeping sickness
Press release
Experts at the University of Dundee have been awarded £2.4 million to identify compounds that could pave the way for a single dose treatment for malaria.
Press release
A new translational research centre will bolster the University of Dundee’s world-leading position in a field that is revolutionising drug discovery, while helping to facilitate the development of high growth companies and create skilled jobs.
Press release
Amphista Therapeutics, a University of Dundee spinout company, has announced a near-£40 million investment that will further its work to develop new drugs for a range of diseases.
Press release
Work to build on Dundee’s world-class expertise in biomedical sciences is set to begin in earnest after the ‘Growing the Tay Cities Biomedical Cluster’ project was officially signed off by the Tay Cities Region Joint Committee today (February 19).
News
Michele Tinti, a postdoctoral researcher in Mike Ferguson’s lab, has competed on the international stage to search for a stable mRNA sequence in order to create a stable COVID-19 vaccine.
Press release
A University of Dundee spinout company developing treatments for eczema, rheumatoid arthritis and other inflammatory conditions has completed its first round of private investment.
News
Dr Manu De Rycker has become an Independent Investigator and has been awarded a New Investigator Research Grant of over £700k from the Medical Research Council (MRC) to study Trypanosoma cruzi parasite heterogeneity and persister parasites.
News
The o2h human health EIS Fund has announced its intention to lead an investment into In4Derm.
Press release
Three spinout projects from the University of Dundee with the potential to deliver significant healthcare benefits have received more than £250,000 from Scottish Enterprise to support their development.
Press release
The University of Dundee is to partner with global biopharmaceutical company Almirall to develop new treatments for severe skin diseases with high level of unmet medical need.
Press release
Researchers at the University of Dundee are looking to transform pharmaceutical and cosmetics testing with their spinout venture that offers an alternative for many experiments currently only performed in animals.
News
Joana Faria has been awarded a SULSA Early Career Research Prize for Development and Regulation.
News
The finalists for Converge 2020, Scotland’s leading academic company creation programme, have been announced with representation from the School included on the list with Dr Robyn Hickerson, Co-founder and Chief Scientific Officer of Ten Bio.
Feature
Since the end of June, our researchers have been returning to the School of Life Sciences to restart their lab-based research. This work encompasses a diverse range of topics from microbiology to gene regulation and plant sciences to drug discovery.
Press release
The University of Dundee’s Drug Discovery Unit (DDU) has received €5 million of funding to develop antiviral treatments for Covid-19 and future coronaviruses.